Literature DB >> 15673340

A cost-benefit analysis of external hip protectors in the nursing home setting.

Lisa A Honkanen1, Bruce R Schackman, Alvin I Mushlin, Mark S Lachs.   

Abstract

OBJECTIVES: To estimate potential cost savings generated by a program of hip protectors in the nursing home from a Medicare perspective.
DESIGN: A state-transition Markov model considering short-term and long-term outcomes of hip protectors for a hypothetical nursing home population, stratified by age, sex, and functional status. Costs, transition probabilities between health states, and estimates of hip protectors' effectiveness were derived from published secondary data.
SETTING: Nursing home facilities in the United States. PARTICIPANTS: Hypothetical cohort of permanent nursing home residents aged 65 and older without a previous hip fracture. INTERVENTION: Program of hip protectors reimbursed by Medicare. MEASUREMENTS: Number of fractures, life years, and dollars saved.
RESULTS: Three pairs of hip protectors replaced annually would result in a weighted average lifetime absolute risk reduction for hip fracture of 8.5%, with net lifetime savings to Medicare of 223 dollars per resident. When the annual cost of hip protectors is less than 151 dollars per person, relative risk of fracture is less than or equal to 0.65 with hip protectors, or adherence is greater than 42%, hip protectors are cost saving to Medicare over a wide range of assumptions. Extrapolating these results to the estimated population of U.S. nursing home residents without a previous hip fracture, Medicare could save 136 million dollars in the first year of a hip-protector reimbursement program.
CONCLUSION: From a Medicare perspective, hip protectors are a cost-saving intervention in the nursing home setting when hip protector effectiveness is less than or equal to 0.65 over the remaining lifetime of subjects.

Entities:  

Mesh:

Year:  2005        PMID: 15673340     DOI: 10.1111/j.1532-5415.2005.53102.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  9 in total

1.  Systematic review of unintentional injury prevention economic evaluations 2010-2019 and comparison to 1998-2009.

Authors:  Mallika Mahalingam; Cora Peterson; Gwen Bergen
Journal:  Accid Anal Prev       Date:  2020-09-09

Review 2.  [The role of hip protectors in the prevention of hip fractures in older people].

Authors:  Lukas A Holzer; Gerold Holzer
Journal:  Wien Med Wochenschr       Date:  2007

3.  Cost Effectiveness of Falls and Injury Prevention Strategies for Older Adults Living in Residential Aged Care Facilities.

Authors:  Jody L Church; Marion R Haas; Stephen Goodall
Journal:  Pharmacoeconomics       Date:  2015-12       Impact factor: 4.981

Review 4.  Hip protectors are cost-effective in the prevention of hip fractures in patients with high fracture risk.

Authors:  R T A L de Bot; H D Veldman; A M Witlox; L W van Rhijn; M Hiligsmann
Journal:  Osteoporos Int       Date:  2020-02-10       Impact factor: 4.507

5.  Could a policy of provision of hip protectors to elderly nursing home residents result in cost savings in acute hip fracture care? The case of Ontario, Canada.

Authors:  A M Sawka; A Gafni; P Boulos; K Beattie; A Papaioannou; A Cranney; D A Hanley; J D Adachi; A Cheung; E A Papadimitropoulos; L Thabane
Journal:  Osteoporos Int       Date:  2007-01-13       Impact factor: 5.071

6.  Hospitalizations during the last months of life of nursing home residents: a retrospective cohort study from Germany.

Authors:  Heribert Ramroth; Norbert Specht-Leible; Hans-Helmut König; Hermann Brenner
Journal:  BMC Health Serv Res       Date:  2006-06-08       Impact factor: 2.655

7.  Validation and psychometric properties of the commitment to hip protectors (C-HiP) index in long-term care providers of British Columbia, Canada: a cross-sectional survey.

Authors:  Alexandra M B Korall; Judith Godin; Fabio Feldman; Ian D Cameron; Pet-Ming Leung; Joanie Sims-Gould; Stephen N Robinovitch
Journal:  BMC Geriatr       Date:  2017-05-03       Impact factor: 3.921

8.  Nonpharmacological prevention of osteoporotic fractures.

Authors:  Cathy R Kessenich
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

9.  Cost-effectiveness of single-dose zoledronic acid for nursing home residents with osteoporosis in the USA.

Authors:  Kouta Ito
Journal:  BMJ Open       Date:  2018-09-04       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.